|
Market Cap (17-May) $614,874,944 (281st) |
Close (30-Jun) $3.44 |
Volume (30-Jun) 301,613 |
Shortsold (5-May) 5,242,611 (2.64%) (96th) |
|
52w High $3.81 |
52w Low $2.06 |
P/E 14.73 |
EPS 0.15 |
ACL released this announcement to the ASX on 7 December 2021, 13:53. The announcement is not marked as price sensitive, and is 11 page(s) in length and 383.14kb in size.
You can view all announcements from ACL and see how they appear on a price chart on the announcements page.
At the date of this announcement, ACL was 0.270% short sold according to ASIC data. It was ranked the 362nd most shorted stock on the ASX. It is now ranked as the 96th most shorted stock on the ASX with 2.643% of total shares short sold as of the latest reported data (05 May 2025).
| Other Recent Announcements from ACL | |
|---|---|
| HLS: Directors' Statement re Takeover | 23 May 2023, 9:09 |
| Response to Healius' Target's Statement | 22 May 2023, 9:55 |
| Second Supplementary Bidder's Statement | 22 May 2023, 9:41 |
| Amended Securities Trading Policy | 7 December 2021, 13:53 |
| Change in substantial holding | 26 November 2021, 16:20 |
| Change of Director's Interest Notice | 22 November 2021, 10:31 |
| Medlab Pathology - Investor Presentation | 15 November 2021, 8:52 |
You must be logged in to post a reply.
